Soluble amyloid composition links proximal APP processing, fibrillar burden and the p-tau181 response
Related Experiment Video
Updated: Nov 9, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Abstract:
Amyloid biomarkers sample distinct levels of an open, kinetically coupled biochemical system, yet scalar summaries may obscure biologically relevant configuration. We asked whether separating shared soluble-peptide variation from Aβ42-selective depletion preserves information and clarifies the amyloid context of the soluble tau response. In 380 Alzheimer's Disease Neuroimaging Initiative participants, CSF Aβ38, Aβ40 and Aβ42 mass-spectrometry measurements were used to derive two peptide-only analytical constructs: variation shared by Aβ38 and Aβ40 (T), and Aβ42-selective depletion relative to their joint profile (D42). BACE activity and sAPPβ preferentially aligned with T (incremental-R² separation 0.463; 95% bootstrap interval 0.361-0.535). D42 was preferentially associated with later fibrillar burden: among 91 participants with PET a median 4.98 years later, the D42-T contrast was 31.21 Centiloids/SD (95% CI 11.12-51.30). In 375 participants, p-tau181 was independently associated with both constructs (standardized coefficients 0.518 and 0.472), mapping across the T-D42 state space and revealing a supported region of elevated soluble tau. Information-retention analyses showed that tested scalar compressions discarded readout-relevant information. Together, these findings support a two-coordinate representation of soluble amyloid state that preserves biologically relevant information obscured by scalar summaries and locates the soluble tau response within the joint peptide configuration.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction

